loader image
Close
  • GMP
  • FDA Academy
  • Downloadables
  • Bids and Awards
  • Careers
  • FAQs
  • Report
  • Contact Us
Menu
  • GMP
  • FDA Academy
  • Downloadables
  • Bids and Awards
  • Careers
  • FAQs
  • Report
  • Contact Us
Facebook
Youtube
  • Home
  • About FDA
  • Transparency
  • Issuances
    • Advisories
    • Administrative Order
    • Executive Order
    • FDA Circular
    • FDA Memorandum
    • Memorandum Circular
    • Republic Act
    • Archives
  • Services
    • eServices
    • ePortal
    • ePortal2
    • BOSS
    • Doctrack
Menu
  • Home
  • About FDA
  • Transparency
  • Issuances
    • Advisories
    • Administrative Order
    • Executive Order
    • FDA Circular
    • FDA Memorandum
    • Memorandum Circular
    • Republic Act
    • Archives
  • Services
    • eServices
    • ePortal
    • ePortal2
    • BOSS
    • Doctrack

Author: Administrator2

FDA Advisory No.2021-0723 || Public Health Warning Against the Continuous Selling of the Unregistered Drug Product Lianhua Qingwen Jiaonang with Chinese Characters

The Food and Drug Administration (FDA) advises the public on the ongoing distribution and/or selling of the following unregistered drug product: Lianhua Qingwen Jiaonang with Chinese Characters As per continuing […]

FDA Advisory No.2021-0722-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng Hindi Rehistradong Gamot na “L.A Salicylic Acid 3% Solution 25mL”

Pinapayuhan ng Food and Drug Administration (FDA) ang publiko laban sa pagbili at paggamit ng hindi rehistradong gamot na: Napatunayan sa pamamagitan ng isinagawang Post-Marketing Surveillance (PMS) ng FDA na […]

FDA Advisory No.2021-0722 || Public Health Warning Against the Purchase and Use of the Unregistered Drug Product “L.A Salicylic Acid 3% Solution 25mL”

 The Food and Drug Administration (FDA) advises the public against the purchase and use of the unregistered drug product: FDA Post-Marketing Surveillance (PMS) activities have verified that the abovementioned drug […]

FDA Advisory No.2021-0721-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng mga Sumusunod na Hindi Rehistradong Gamot:

Pinapayuhan ng Food and Drug Administration (FDA) ang publiko laban sa pagbili at paggamit ng mga sumusunod na hindi rehistradong gamot: 1. Tasly® Compound Danshen Dripping Pills 2. Jucishan® Dexamethasone […]

FDA Advisory No.2021-0721 || Public Health Warning Against the Purchase and Use of the Following Unregistered Drug Products:

The Food and Drug Administration (FDA) advises the public against the purchase and use of the following unregistered drug products: 1. Tasly® Compound Danshen Dripping Pills 2. Jucishan® Dexamethasone Sodium […]

FDA Advisory No.2021-0720-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng mga Sumusunod na Hindi Rehistradong Gamot:

Pinapayuhan ng Food and Drug Administration (FDA) ang publiko laban sa pagbili at paggamit ng mga sumusunod na hindi rehistradong gamot: 1. OTC Fuke Qianjin Pian [as reflected in the […]

FDA Advisory No.2021-0720 || Public Health Warning Against the Purchase and Use of the Following Unregistered Drug Products:

The Food and Drug Administration (FDA) advises the public against the purchase and use of the following unregistered drug products: 1. OTC Fuke Qianjin Pian [as reflected in the package […]

FDA Advisory No.2021-0719-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng Hindi Rehistradong Gamot na “Vino Apostolado (12 Medicinal Mint Herbs) 120mL”

Pinapayuhan ng Food and Drug Administration (FDA) ang publiko laban sa pagbili at paggamit ng hindi rehistradong gamot na: 1. Vino Apostolado (12 Medicinal Mint Herbs) 120mL Napatunayan sa pamamagitan […]

FDA Advisory No.2021-0719 || Public Health Warning Against the Purchase and Use of the Unregistered Drug Product “Vino Apostolado (12 Medicinal Mint Herbs) 120mL”

The Food and Drug Administration (FDA) advises the public against the purchase and use of the unregistered drug product: Vino Apostolado (12 Medicinal Mint Herbs) 120mL FDA Post-Marketing Surveillance (PMS) […]

FDA Advisory No.2021-0718-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng mga Sumusunod na Hindi Rehistradong Gamot:

Pinapayuhan ng Food and Drug Administration (FDA) ang publiko laban sa pagbili at paggamit ng mga sumusunod na hindi rehistradong gamot: 1. OTC Changyanning Jiaonang [as reflected in the package […]

← older
Quick Menus

GMP

FDA ACADEMY

DOWNLOADABLES

CAREERS

FAQs

CONTACT US

Recent Posts
  • Clarification on the Approval and Use of Leronlimab

  • FDA Advisory No.2021-0723 || Public Health Warning Against the Continuous…

  • FDA Advisory No.2021-0722-A || Babala sa Publiko Tungkol sa Pagbili…

  • FDA Advisory No.2021-0722 || Public Health Warning Against the Purchase…

Quick Links
  • Department of Health (DOH)
  • U.S Food and Drug Administration (U.S FDA)
  • Department of Information and Communications Technology (DICT)
  • Department of Science and Technology (DOST)
  • Anti-Red Tape Authority (ARTA)
Contact Information
Address:

Civic Drive Filinvest Corporate City

Alabang, Muntinlupa City
Tel. no: +632 8 857-1900
[email protected]
 

 
Landline: 

(8) 821-1177
(8) 821-1176
(8) 821-1220
(8) 821-1162
(8) 821-1159

Mobile:

0961-6804447
0961-7709691
0961-6845994

Email: [email protected]

Copyright © 2021. All Rights Reserved.